Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat

Addiction Biology

Volumn 16, Issue 1, 2011, Pages 20-29

  Häggkvist, Jenny ^a   Björkholm, Carl ^a   Steensland, Pia ^a   Lindholm, Sara ^a,b   Franck, Johan ^a   Schilström, Björn ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Conditioned response; context; dependence; opioid antagonist; psychostimulant; relapse

Indexed keywords

AMPHETAMINE; NALTREXONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; ASSOCIATION LEARNING; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; CUES; DEXTROAMPHETAMINE; MALE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; PREMEDICATION; RATS; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 78649941342     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2009.00199.x     Document Type: Article

References (62)

1. Adams PM, Beauchamp R, Alston C, (1981) Potentiation of apomorphine and d-amphetamine effects by naloxone. Life Sci 28: 629-634.
2. American Psychiatric Association AP (1994) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
3. Anagnostaras SG, Schallert T, Robinson TE, (2002) Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology 26: 703-715.
4. Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T, (2004) Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward. Brain Res 1021: 272-276.
5. Arnsten AT, Segal DS, (1979) Naloxone alters locomotion and interaction with environmental stimuli. Life Sci 25: 1035-1042.
6. Azzaro AJ, Rutledge CO, (1973) Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain. Biochem Pharmacol 22: 2801-2813.
7. Badiani A, Anagnostaras SG, Robinson TE, (1995) The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology 117: 443-452.
8. Balcells-Olivero M, Vezina P, (1997) Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections. Psychopharmacology 131: 230-238.
9. Bienkowski P, Kostowski W, Koros E, (1999) Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur J Pharmacol 374: 321-327.
10. Blumberg H, Dayton HB, (1973) Naloxone, naltrexone, and related noroxymorphones. Adv Biochem Psychopharmacol 8: 33-43.
11. Burattini C, Burbassi S, Aicardi G, Cervo L, (2008) Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats. Int J Neuropsychopharmacol 11: 103-109.
12. Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP, (1993) Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 137: 73-95.
13. Curran EJ, Watson SJ Jr, (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J Comp Neurol 361: 57-76.
14. Dettmar PW, Cowan A, Walter DS, (1978) Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats. Neuropharmacology 17: 1041-1044.
15. Di Chiara G, Imperato A, (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278.
16. Gerrits MAFM, Kuzmin AV, Van Ree JM, (2005) Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Eur Neuropsychopharmacol 15: 297-303.
17. Holtzman SG, (1974) Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 189: 51-60.
18. Holtzman SG, (1976) Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat. Psychopharmacologia 46: 223-227.
19. Hooks MS, Jones DNC, Justice JB, Holtzman SG, (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42: 765-770.
20. Häggkvist J, Lindholm S, Franck J, (2009a) The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat. Behav Brain Res 197: 219-224.
21. Häggkvist J, Lindholm S, Franck J, (2009b) The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict Biol 14: 260-269.
22. Jaffe JH, Cascella NG, Kumor KM, Sherer MA, (1989) Cocaine-induced cocaine craving. Psychopharmacology 97: 59-64.
23. Jayaram-Lindström N, Hammarberg A, Beck O, Franck J, (2008a) Naltrexone for the treatment of amphetamine dependence: a randomized placebo controlled trial. Am J Psychiatry 165: 1442-1448.
24. Jayaram-Lindström N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J, (2008b) Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33: 1856-1863.
25. Jayaram-Lindström N, Wennberg P, Beck O, Franck J, (2005) An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability. Nord J Psychiatry 59: 167-171.
26. Jayaram-Lindström N, Wennberg P, Hurd YL, Franck J, (2004) Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24: 665-669.
27. Kalivas PW, Widerlov E, Stanley D, Breese G, Prange AJ Jr, (1983) Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227: 229-237.
28. Koob G, Le Moal M, (2006) Neurobiology of Addiction, Oxford, UK: Elsevier, Academic Press.
29. Liu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth S, (2009) Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. Psychopharmacology 202: 589-598.
30. Magendzo K, Bustos G, (2003) Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of [mu]- and [delta]-opioid receptors. Neuropsychopharmacology 28: 468-477.
31. Magos L, (1969) Persistence of the effect of amphetamine on stereotyped activity in rats. Eur J Pharmacol 6: 200-201.
32. Mansour A, Fox CA, Akil H, Watson SJ, (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29.
33. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ, (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11: 308-314.
34. Marinelli PW, Funk D, Juzytsch W, Li Z, Le AD, (2007) Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur J Neurosci 26: 2815-2823.
35. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB, (1999) Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23: 1386-1394.
36. Nieto MM, Wilson J, Cupo A, Roques BP, Noble F, (2002) Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J Neurosci 22: 1034-1041.
37. O'Brien CP, (2005) Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 162: 1423-1431.
38. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B, (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49: 881-887.
39. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ, (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology 160: 19-29.
40. Olive MF, Koenig HN, Nannini MA, Hodge CW, (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci 21: 1-5.
41. Pickens RW, Crowder WF, (1967) Effects of CS-US interval on conditioning of drug response, with assessment of speed of conditioning. Psychopharmacologia 11: 88-94.
42. Rawson RA, Condon TP, (2007) Why do we need an Addiction supplement focused on methamphetamine? Addiction 102 (Suppl. 1): 1-4.
43. Robinson TE, Becker JB, (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396: 157-198.
44. Robinson TE, Berridge KC, (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
45. Robinson TE, Berridge KC, (2003) Addiction. Annu Rev Psychol 54: 25-53.
46. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB, (2000) Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109: 738-742.
47. Sala M, Braida D, Colombo M, Groppetti A, Sacco S, Gori E, Parenti M, (1995) Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther 274: 450-457.
48. Schaefer GJ, Michael RP, (1990) Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats. Psychopharmacology 102: 263-268.
49. Segal DS, Mandell AJ, (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2: 249-255.
50. Sesack SR, Pickel VM, (1992) Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions. J Neurosci 12: 1335-1350.
51. Sinha R, (2001) How does stress increase risk of drug abuse and relapse? Psychopharmacology 158: 343-359.
52. Smith AJ, McGinty JF, (1994) Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Brain Res Mol Brain Res 21: 359-362.
53. Spanagel R, Herz A, Shippenberg TS, (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55: 1734-1740.
54. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P, (2001) Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev CD003022.
55. Tang XC, McFarland K, Cagle S, Kalivas PW, (2005) Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci 25: 4512-4520.
56. Tilson H, Rech R, (1973) Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity. Pharmacol Biochem Behav 1: 149-153.
57. Todtenkopf MS, O'Neill KS, Kriksciukaite K, Turncliff RZ, Dean RL, Ostrovsky-Day I, Deaver DR, (2009) Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats. Addict Biol 14: 408-418.
58. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP, (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876-880.
59. Wang JQ, Smith AJ, McGinty JF, (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68: 83-95.
60. Winslow JT, Miczek KA, (1988) Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology 96: 493-499.
61. Zhou W, Mailloux AW, Jung BJ, Edmunds HS Jr, McGinty JF, (2004) GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Brain Res 1004: 18-28.
62. Zhou W, Zhang F, Liu H, Tang S, Lai M, Zhu H, Kalivas PW, (2009) Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse. Psychopharmacology 203: 677-684.